Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Clinically Relevant Drug Product Specifications: Methods of Establishment

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

In Vitro Drug Release Testing: Overview, Development and Validation

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...

Bioequivalence studies: Biowaivers

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sparse Canonical Correlation Analysis for Multiple Measurements With Latent Trajectories.

Biometrical journal. Biometrische Zeitschrift·2025

Same author

Estimating overall survival of glioblastoma patients using clinical variables, tumor size, and location.

Neuro-oncology advances·2025

Same author

Identifying Predictors for Heart Failure Outcomes in Phospholamban p.(Arg14del)-Positive Individuals.

JACC. Heart failure·2025

Same author

Application of image guided analyses to monitor fecal microbial composition and diversity in a human cohort.

Scientific reports·2025

Same author

Aortic Function in a Longitudinal 4D Flow MRI Study in Marfan Syndrome Patients Receiving Resveratrol.

Journal of magnetic resonance imaging : JMRI·2025

Same author

Cohort Profile Update: The Healthy Life in an Urban Setting (HELIUS) Study.

International journal of epidemiology·2025

Search research articles

Related Experiment Video

Updated: Jul 2, 2026

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

Novel procedures for validating surrogate endpoints in clinical trials.

Ton J Cleophas¹, Aeilko H Zwinderman, Amel H Chaib

¹Department of Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands. ajm.cleophas@wxs.nl

Current Clinical Pharmacology

|August 12, 2008

Summary

New validation methods for surrogate endpoints in clinical trials are proposed. These procedures address limitations of existing sensitivity-specificity and regression approaches, aiming for more reliable surrogate marker validation in medical research.

Related Experiment Videos

Last Updated: Jul 2, 2026

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

Area of Science:

Clinical Trials Methodology
Biostatistics
Biomarker Validation

Background:

International Conference of Harmonisation (ICH) Guideline E9 recommends validation of surrogate endpoints using sensitivity-specificity or regression analysis.
Existing methods face challenges: difficulty in achieving overall validity (sensitivity-specificity) and insufficient predictive power indication (regression analysis).

Purpose of the Study:

To present novel procedures for validating surrogate endpoints, specifically designed to overcome limitations of current approaches.
To offer accessible methods for a non-mathematical audience to ensure robust surrogate marker utility in clinical trials.

Main Methods:

For dichotomous surrogate tests, an overall validity level (percentage of correctly classified patients) with confidence intervals was employed.
For continuous surrogate variables, regression analysis was adapted to consider correlations between surrogate and true endpoints, and their relation to treatment modalities.
Validation criteria included confidence intervals within a prespecified validity range and surrogate endpoint explaining ≥70% of true endpoint variability.

Main Results:

The proposed overall validity level approach provides a clearer measure of surrogate test performance.
The refined regression analysis accounts for crucial confounding factors, improving the assessment of surrogate endpoint predictive value.
A threshold of 70% explained variability in the true endpoint by the surrogate was established for validation.

Conclusions:

The developed methods offer improved validation of surrogate endpoints compared to traditional sensitivity-specificity and basic regression analyses.
These approaches aim to enhance the reliability of surrogate markers, thereby improving the validity and impact of future clinical trials.
Careful consideration of the surrogate's relationship with treatment is crucial for accurate validation.